Sanofi (OTCMKTS:SNYNF – Get Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totaling 167,782 shares, a decline of 39.1% from the May 31st total of 275,393 shares. Based on an average trading volume of 6,920 shares, the short-interest ratio is currently 24.2 days.
Sanofi Stock Down 1.0%
Shares of Sanofi stock opened at $83.55 on Wednesday. The company has a 50 day moving average price of $87.71 and a 200 day moving average price of $91.62. Sanofi has a 52 week low of $80.74 and a 52 week high of $106.34.
Sanofi Company Profile
Sanofi is a multinational biopharmaceutical company headquartered in Paris, France, specializing in the research, development and manufacturing of prescription medicines, vaccines and consumer healthcare products. With a strategic focus on specialty care, vaccines, and general medicines, Sanofi’s portfolio addresses a broad range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology and rare diseases. The company operates through distinct business segments, each dedicated to advancing patient care through innovative therapies and preventive solutions.
In its pharmaceuticals segment, Sanofi develops and markets biologics and small molecules designed to treat chronic and acute conditions.
Recommended Stories
- Five stocks we like better than Sanofi
- Burger King’s Turnaround Is Putting Restaurant Brands Back in Focus
- Short Squeeze Alert—Moderna Stock Surges on New Strategy
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.
